What do Rollerblades and Ozempic have in common?

In a new episode of STATus Report, host Alex Hogan explains what happens when brand-name drugs are at risk of "genericide."

October 29, 2025 Check out STAT+

Sponsored By

Lexey Swall for STAT Scientists had to change more than 700 grant titles to receive NIH funding. Health disparities researchers fear what's next NIH denies having a banned words list but a new analysis finds hundreds of grant titles were changed to avoid terms like equity, disparity, and minority. By Anil Oza STAT+ | FDA moves to ease path for biosimilars as Trump seeks to cut drug costs The FDA wants to make it quicker to approve biosimilars, part of President Trump's efforts to lower U.S. drug prices. By Daniel Payne Opinion: A 'devil's choice' on vaccines and pandemic preparedness Global vaccine expert Seth Berkley on what went right and wrong with Covid — and preparing for the next pandemic. By Torie Bosch Alex Hogan/STAT What do Rollerblades and Ozempic have in common? Ozempic is sold for diabetes but has become synonymous with weight loss drugs. Will the trademark go the way of aspirin and dumpsters? By Alex Hogan Trump team takes aim at state laws shielding consumers' credit scores from medical debt Nationwide, about 100 million people have some form of health care debt, with millions burdened by $10,000 or more in unpaid bills. By Noam N. Levey — KFF Health News Opinion: Doctors need to ask patients about chatbots In addition to sleep, exercise, and diet, doctors should ask their patients about use of chatbots. By Saneha Borisuth and Nina Vasan Adobe Opinion: 'AI psychosis' discussions ignore a bigger problem with chatbots Relying on chatbots is the predictable result of physical and mental health care made scarce, stigmatized, and costly. By Valerie Black

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser